Olympus (OTCMKTS:OCPNY) Stock Passes Above Fifty Day Moving Average – What’s Next?

Olympus Co. (OTCMKTS:OCPNY) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $18.00 and traded as high as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded shares of Olympus to a “buy” rating in a report on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy”.

Olympus Stock Performance

The stock’s 50 day moving average is $18.00 and its two-hundred day moving average is $18.00. The stock has a market capitalization of $23.15 billion, a price-to-earnings ratio of 21.95, a price-to-earnings-growth ratio of 1.07 and a beta of 0.70. The company has a current ratio of 1.99, a quick ratio of 1.48 and a debt-to-equity ratio of 0.59.

Olympus Company Profile

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.